- Home
- AUTL vs CPAC Comparison
AUTL vs CPAC Comparison
Compare AUTL & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- CPAC
- Stock Information
- Founded
- AUTL 2014
- CPAC 1949
- Country
- AUTL United Kingdom
- CPAC Peru
- Employees
- AUTL N/A
- CPAC N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- CPAC Building Materials
- Sector
- AUTL Health Care
- CPAC Industrials
- Exchange
- AUTL Nasdaq
- CPAC Nasdaq
- Market Cap
- AUTL 590.8M
- CPAC 505.3M
- IPO Year
- AUTL 2018
- CPAC 2012
- Fundamental
- Price
- AUTL $1.44
- CPAC $5.81
- Analyst Decision
- AUTL Strong Buy
- CPAC Sell
- Analyst Count
- AUTL 5
- CPAC 1
- Target Price
- AUTL $9.32
- CPAC $6.00
- AVG Volume (30 Days)
- AUTL 1.3M
- CPAC 3.2K
- Earning Date
- AUTL 05-13-2025
- CPAC 04-28-2025
- Dividend Yield
- AUTL N/A
- CPAC 8.63%
- EPS Growth
- AUTL N/A
- CPAC 17.75
- EPS
- AUTL N/A
- CPAC 0.12
- Revenue
- AUTL $10,120,000.00
- CPAC $524,464,683.00
- Revenue This Year
- AUTL $277.74
- CPAC N/A
- Revenue Next Year
- AUTL $221.89
- CPAC N/A
- P/E Ratio
- AUTL N/A
- CPAC $9.63
- Revenue Growth
- AUTL 496.00
- CPAC 1.44
- 52 Week Low
- AUTL $1.40
- CPAC $5.10
- 52 Week High
- AUTL $5.84
- CPAC $6.65
- Technical
- Relative Strength Index (RSI)
- AUTL 32.97
- CPAC 54.59
- Support Level
- AUTL $1.58
- CPAC $5.71
- Resistance Level
- AUTL $1.70
- CPAC $5.95
- Average True Range (ATR)
- AUTL 0.13
- CPAC 0.03
- MACD
- AUTL -0.02
- CPAC 0.01
- Stochastic Oscillator
- AUTL 3.03
- CPAC 100.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.